Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1738]
News [4521]
Articles [207]
Editorials [9]
Conferences [164]
elearning [24]
Six-month follow up of CTL019 for diffuse large B-cell lymphoma
Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Six-month follow up of CTL019 for diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017
Anti-BCMA CAR T cell therapy for multiple myeloma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Anti-BCMA CAR T cell therapy for multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
10 Dec 2017
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial
Prof Peter Hillmen - University of Leeds, Leeds, UK
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B...
Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's...
Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017
Long term follow up on the ZUMA-1 trial for nHL
Dr Sattva Neelapu - MD Anderson Center, Houston, USA
Long term follow up on the ZUMA-1 trial for nHL ( Dr Sattva Neelapu - MD Anderson Center, Houston, USA )
10 Dec 2017
BLU-285 for advanced systemic mastocytosis
Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
BLU-285 for advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017
SABCS 2017: The latest in CDK inhibition in breast cancer
Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz
SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )
10 Dec 2017
Autologous haematopoietic cell transplant for mantle cell lymphoma
Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA
Autologous haematopoietic cell transplant for mantle cell lymphoma ( Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA )
9 Dec 2017
Dexamethasone and the UKALL 2011 trial
Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Dexamethasone and the UKALL 2011 trial ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
9 Dec 2017
Circulating tumour cells may predict late recurrence in HR-positive breast...
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
9 Dec 2017
Postmenopausal women who lose weight may have reduced breast cancer risk
Prof Rowan Chlebowski - City of Hope, Duarte, USA
Postmenopausal women who lose weight may have reduced breast cancer risk ( Prof Rowan Chlebowski - City of Hope, Duarte, USA )
9 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation